In anticipation of a possible surge in hospitalizations and taking into account recent evidence, (and limited supplies of some therapeutics) we are delighted to present our revised (v9) guidelines! Main changes compared to previous version are highlighted in "SUMMARY of changes" . As always, these guidelines are the product of thoughtful discussions between ID and pharmacy experts, with input from a multidisciplinary group of colleagues.
HAPPY HOLIDAY SEASON to all, from the ASP team!!